Merck

Pneumovax 23

Manufacturer:

Merck

Pneumovax 23 HCPCS:

90732

HCPCS Code Descriptor:

Pneumococcal polysaccharide vaccine, 23-valent, adult or immunosuppressed patient?dosage, for use in individuals 2 years or older, for subcutaneous or intramuscular use;

Category:

CPT Drug Code

Pneumovax 23 NDCs:

00006-4943-00, 00006-4837-03

Primary Type:

Vaccine-Pneumococcal

Generic/Specialty Status:

Single-Source

Route of Administration:

Injection

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Pneumovax 23:

Pneumovax 23 is a Vaccine-Pneumococcal drug manufactured by Merck and administered via the Injection route of administration. The CPT Drug Code: 90732 is aligned to the drug Pneumovax 23.

Pneumovax 23 is a Pneumococcal vaccine for active immunization. It is used to prevent pneumococcal disease caused by the 23 serotypes contained in the vaccine. Pneumococcal disease is any illness that is caused by pneumococcal bacteria. Pneumococcal bacteria are one of the most common causes of pneumonia, but the bacteria can also cause ear infections, sinus infections, meningitis, bacteremia. Children under 2, adults 65 and older, those with certain pre-existing conditions, and cigarette smokers have elevated risks of pneumococcal disease.

ACCESS PRICING AND MORE BY REGISTERING

90732 Added Date:

NA

90732 Effective Date:

NA

90732 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Pneumovax 23 billing and coding information.
Pneumovax 23 patient assistance information can be found through the Merck Helps Program at the URL: http://www.merckhelps.com/
Pneumovax 23 prescribing information can be found at the link below:
Information regarding Pneumovax 23’s side effects can be found at MedlinePlus